Antibody
Antibodies are constantly being developed in order to protect the immune system from harmful pathogens. For example, a team of researchers is working on creating a monoclonal antibody that combats Human T-cell leukemia virus type-1 (HTLV-1). The antibody specifically targets the HTLV-1 envelope protein gp46 glycoprotein as a means of destroying HTLV-1-infected cells. The results of the study demonstrate that antibodies can be developed as a therapeutic tool against pathogen-infected cells, thereby serving as a means of treating diseases caused by said pathogens.